EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma.
about
EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
EphA2 chimeric antigen recepto ...... ageal squamous cell carcinoma.
@en
EphA2 chimeric antigen recepto ...... ageal squamous cell carcinoma.
@nl
type
label
EphA2 chimeric antigen recepto ...... ageal squamous cell carcinoma.
@en
EphA2 chimeric antigen recepto ...... ageal squamous cell carcinoma.
@nl
prefLabel
EphA2 chimeric antigen recepto ...... ageal squamous cell carcinoma.
@en
EphA2 chimeric antigen recepto ...... ageal squamous cell carcinoma.
@nl
P2093
P2860
P356
P1476
EphA2 chimeric antigen recepto ...... ageal squamous cell carcinoma.
@en
P2093
Jiahai Shi
Maorong Jiang
Peiwen Wang
Qianqian Ju
Yingcheng Wu
Yinting Mao
P2860
P304
P356
10.21037/JTD.2018.04.91
P577
2018-05-01T00:00:00Z